News

February 10, 2020

Enteris BioPharma
Appoints Gary A.
Shangold, MD, as Chief Medical Officer

Accomplished biopharma and drug development executive to lead expansion of Enteris’ internal and external development programs. Boonton, NJ – February 10, 2020 – Enteris BioPharma, Inc., […]
January 29, 2020

Enteris BioPharma Awarded 2019 Best of Boonton Prize

Enteris recognized for enhancing positive image of small businesses and service to customers. Award received from the Boonton Award Program, in the Pharmaceutical Company category Recognizes […]
January 7, 2020

Enteris BioPharma Highlights 2019 Achievements and
2020 Outlook

A transformational 2019 positions Enteris to capitalize on potential of Peptelligence® Acquired by SWK Holdings Corporation; Now Operating as a Wholly Owned Subsidiary Focused on Advancement […]
December 6, 2019

KORSUVA™
Top Line Data
Phase 2 CKD

Oral KORSUVA 1 mg met primary endpoint with statistically significant reduction in mean worst itching intensity NRS scores vs. placebo after 12-week treatment period (p=0.018) Oral […]
August 27, 2019

SWK Holdings
Corporation Acquires
Enteris BioPharma

SWK Holdings Corporation acquires 100% of Enteris’ equity from Victory Park Capital Enteris to operate as an independent, wholly-owned subsidiary of SWK, targeting opportunities to develop […]
August 21, 2019

New Licensing
Agreement for
Oral KORSUVA™ with
Peptelligence®

Enteris BioPharma and Cara Therapeutics Enter into Licensing Agreement for Peptelligence® to Advance Development of Oral KORSUVA™ Deal Showcases the Potential of Peptelligence® as the “Gold […]
July 11, 2019

Oral KORSUVA™ in
Phase 2 Clinical Trial
for Atopic Dermatitis

Enteris BioPharma’s “Feasibility-to-Licensing” Partner, Cara Therapeutics, Initiates Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA™ for Pruritus in Patients with Atopic Dermatitis Oral KORSUVA is now the […]

KNOWLEDGE CENTER

Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.

LEARN MORE

KNOWLEDGE CENTER

Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.

LEARN MORE